Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline

2021255 citationsJournal Article

Authors

Megan E. Daly · University of California, Davis

Navneet Singh · Post Graduate Institute of Medical Education and Research

Nofisat Ismaila · American Society of Clinical Oncology

Mara B. Antonoff · The University of Texas MD Anderson Cancer Center

Douglas A. Arenberg · University of Michigan

Jeffrey Bradley · Emory University

Elizabeth David · University of Southern California

Frank Detterbeck

Abstract

Evidence-based recommendations were developed to address evaluation and staging workup of patients with suspected stage III NSCLC, surgical management, neoadjuvant and adjuvant approaches, and management of patients with unresectable stage III NSCLC.Additional information is available at www.asco.org/thoracic-cancer-guidelines.

Topics & Keywords

Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations Lung Cancer Research Studies

Publication Details

Published in: Journal of Clinical Oncology

Volume 40, Issue 12, pp. 1356-1384

DOI: 10.1200/jco.21.02528

Field-Weighted Citation Impact: 23.92

Command Palette

Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline

Authors

Abstract

Topics & Keywords

Publication Details